RETRACTION: Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment

Stem Cells International

Open source

DOI
10.1155/sci/9763520
Published
2026-01
Container
Stem Cells International
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/sci/9763520,
  title = {RETRACTION: Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment},
  author = {Stem Cells International},
  year = {2026},
  journal = {Stem Cells International},
  doi = {10.1155/sci/9763520},
  url = {https://doi.org/10.1155/sci/9763520}
}

RIS

TY  - JOUR
TI  - RETRACTION: Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment
AU  - Stem Cells International
PY  - 2026
JO  - Stem Cells International
DO  - 10.1155/sci/9763520
UR  - https://doi.org/10.1155/sci/9763520
ER  - 

APA

International, S. C. (2026). RETRACTION: Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment. Stem Cells International. https://doi.org/10.1155/sci/9763520

Source records